1
|
Shishparenok AN, Koroleva SA, Dobryakova NV, Gladilina YA, Gromovykh TI, Solopov AB, Kudryashova EV, Zhdanov DD. Bacterial cellulose films for L-asparaginase delivery to melanoma cells. Int J Biol Macromol 2024; 276:133932. [PMID: 39025173 DOI: 10.1016/j.ijbiomac.2024.133932] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2024] [Revised: 06/24/2024] [Accepted: 07/15/2024] [Indexed: 07/20/2024]
Abstract
L-asparaginase (L-ASNase) is an enzyme that catalyzes the hydrolysis of L-asparagine to L-aspartic acid and ammonia and is used to treat acute lymphoblastic leukemia. It is also toxic to the cells of some solid tumors, including melanoma cells. Immobilization of this enzyme can improve its activity against melanoma tumor cells. In this work, the properties of bacterial cellulose (BC) and feasibility of BC films as a new carrier for immobilized L-ASNase were investigated. Different values of growth time were used to obtain BC films with different thicknesses and porosities, which determine the water content and the ability to adsorb and release L-ASNase. Fourier transform infrared spectroscopy confirmed the adsorption of the enzyme on the BC films. The total activity of adsorbed L-ASNase and its release were investigated for films grown for 48, 72 or 96 h. BC films grown for 96 h showed the most pronounced release as described by zero-order and Korsmayer-Peppas models. The release was characterized by controlled diffusion where the drug was released at a constant rate. BC films with immobilized L-ASNase could induce cytotoxicity in A875 human melanoma cells. With further development, immobilization of L-ASNase on BC may become a potent strategy for anticancer drug delivery to superficial tumors.
Collapse
Affiliation(s)
- Anastasiya N Shishparenok
- Laboratory of Medical Biotechnology, Institute of Biomedical Chemistry, 10/8 Pogodinskaya St., 119121 Moscow, Russia
| | - Svetlana A Koroleva
- Laboratory of Medical Biotechnology, Institute of Biomedical Chemistry, 10/8 Pogodinskaya St., 119121 Moscow, Russia; Institute of Biochemical Technology and Nanotechnology, People's Friendship University of Russia Named after Patrice Lumumba (RUDN University), 6 Miklukho-Maklaya St., 117198 Moscow, Russia; ChemBioTech Department, Moscow Polytechnic University, 38 Bolshaya Semenovskaya st., Moscow 107023, Russia
| | - Natalya V Dobryakova
- Laboratory of Medical Biotechnology, Institute of Biomedical Chemistry, 10/8 Pogodinskaya St., 119121 Moscow, Russia
| | - Yulia A Gladilina
- Laboratory of Medical Biotechnology, Institute of Biomedical Chemistry, 10/8 Pogodinskaya St., 119121 Moscow, Russia
| | - Tatiana I Gromovykh
- ChemBioTech Department, Moscow Polytechnic University, 38 Bolshaya Semenovskaya st., Moscow 107023, Russia
| | - Alexey B Solopov
- A.V. Topchiev Institute of Petrochemical Synthesis, RAS (TIPS RAS), 29 Leninsky Prospekt, 119991 Moscow, Russia
| | - Elena V Kudryashova
- Chemical Faculty, Lomonosov Moscow State University, Leninskie Gory St. 1, 119991 Moscow, Russia
| | - Dmitry D Zhdanov
- Laboratory of Medical Biotechnology, Institute of Biomedical Chemistry, 10/8 Pogodinskaya St., 119121 Moscow, Russia.
| |
Collapse
|
2
|
Jiang Y, Yan C, Li M, Chen S, Chen Z, Yang L, Luo K. Delivery of natural products via polysaccharide-based nanocarriers for cancer therapy: A review on recent advances and future challenges. Int J Biol Macromol 2024; 278:135072. [PMID: 39191341 DOI: 10.1016/j.ijbiomac.2024.135072] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2024] [Revised: 08/19/2024] [Accepted: 08/24/2024] [Indexed: 08/29/2024]
Abstract
Cancer, caused by uncontrolled proliferation of abnormal cells, has long been a global public health issue. For decades, natural products have been proven to be an essential source for novel anticancer drug discovery. But their instability, low solubility and bioavailability, poor targeting impede therapeutic efficacy. With the development of nanotechnology, nanomedicine delivery systems have emerged as promising strategies to improve bioavailability and enhance the therapeutic efficacy of drugs. However, constructing suitable nanocarrier is still a major challenge. Polysaccharides are extensively employed as carrier materials in nanomedicine delivery systems, owing to their unique physicochemical properties, biocompatibility and low immunogenicity. Polysaccharide-based nanomedicine delivery systems show high drug delivery efficiency, controlled drug release, and precise tumor targeting. This paper reviews influencing factors in the construction of polysaccharide-based nanocarriers and the application of polysaccharide-based nanocarriers for the delivery of natural products in treating various cancers. It focuses on their in vitro and in vivo anticancer efficacy and mechanisms. Furthermore, the review contrasts the capabilities and limitations of polysaccharide-based nanocarriers with traditional delivery methods, underlining their potential to enable targeted, reduced toxicity and excellent cancer treatment modalities. Finally, we discuss the current research limitations and future prospects in this emerging field.
Collapse
Affiliation(s)
- Yingjie Jiang
- State Key Laboratory of Southwestern Chinese Medicine Resources, Department of Pharmaceutics of Traditional Chinese Medicine, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
| | - Chunmei Yan
- State Key Laboratory of Southwestern Chinese Medicine Resources, Department of Pharmaceutics of Traditional Chinese Medicine, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
| | - Minghao Li
- State Key Laboratory of Southwestern Chinese Medicine Resources, Department of Pharmaceutics of Traditional Chinese Medicine, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
| | - Siying Chen
- State Key Laboratory of Southwestern Chinese Medicine Resources, Department of Pharmaceutics of Traditional Chinese Medicine, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
| | - Zhimin Chen
- State Key Laboratory of Southwestern Chinese Medicine Resources, Department of Pharmaceutics of Traditional Chinese Medicine, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
| | - Lu Yang
- Innovative Institute of Chinese Medicine and Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China; Meishan Hospital of Chengdu University of Traditional Chinese Medicine, Meishan 620010, China.
| | - Kaipei Luo
- State Key Laboratory of Southwestern Chinese Medicine Resources, Department of Pharmaceutics of Traditional Chinese Medicine, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
| |
Collapse
|
3
|
Carvalho APAD, Értola R, Conte-Junior CA. Nanocellulose-based platforms as a multipurpose carrier for drug and bioactive compounds: From active packaging to transdermal and anticancer applications. Int J Pharm 2024; 652:123851. [PMID: 38272194 DOI: 10.1016/j.ijpharm.2024.123851] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2023] [Revised: 01/09/2024] [Accepted: 01/22/2024] [Indexed: 01/27/2024]
Abstract
The nanocellulose has unique characteristics, such as biocompatibility, good mechanical strength, and low cytotoxicity. The nanocellulose crystalline portion is responsible for good mechanical resistance, while the amorphous portion is responsible for flexibility. Such features make it a promising candidate for multiple applications related to the modulation of substance release: targeted cancer therapy, transdermal drug delivery, and controlled-release packaging materials. Thus, in this study, we discussed nanocellulose as a multipurpose material for drug delivery and bioactive compound carriers in controlled delivery systems with varied applications in pharmaceutic fields. Herein, we focus on understanding key factors such as i) polymer-drug interactions and surface modification strategies in controlled release rates, ii) therapeutic efficacy, and iii) biocompatibility aspects. The tunable chemistry surface plays a fundamental approach limiting the quick release of active substances in drug delivery systems. Several works on a pre-clinical stage of investigation were overviewed, reporting robust evidence on nanocellulose to design bioactive compounds/drug delivery carriers based on stimuli-responsive drug release and controlled delivery systems for higher efficiency in cancer therapies, purposing target therapy and reduced side effects. Nanocellulose was also identified as a solid candidate material in active packaging for pharmaceutical products. Cellulose nanocrystals and bacterial cellulose demonstrated strong potential to overcome the challenge of controlled release profile and open novel insights in advanced active packaging materials for pharmaceutics with controlled release of antioxidant and antimicrobial substances. Moreover, the concept overview in this work might be extended in active food packaging technologies to flavor-releasing/absorbing systems or antimicrobial/antioxidant carriers for extending the shelf life of foods.
Collapse
Affiliation(s)
- Anna Paula Azevedo de Carvalho
- Research Support Group on Nanomaterials, Polymers, and Interaction with Biosystems (BioNano), Department of Biochemistry, Chemistry Institute, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ 21941909, Brazil; Center for Food Analysis (NAL), Technological Development Support Laboratory (LADETEC), Chemistry Institute, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ 21941598, Brazil; Nanotechnology Network, Carlos Chagas Filho Research Support Foundation of the State of Rio de Janeiro (FAPERJ), Rio de Janeiro, RJ 20020-000, Brazil; Graduate Program in Chemistry (PGQu), Chemistry Institute, Federal University of Rio de Janeiro, Rio de Janeiro, RJ 21941909, Brazil.
| | - Raphael Értola
- Research Support Group on Nanomaterials, Polymers, and Interaction with Biosystems (BioNano), Department of Biochemistry, Chemistry Institute, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ 21941909, Brazil; Center for Food Analysis (NAL), Technological Development Support Laboratory (LADETEC), Chemistry Institute, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ 21941598, Brazil
| | - Carlos Adam Conte-Junior
- Research Support Group on Nanomaterials, Polymers, and Interaction with Biosystems (BioNano), Department of Biochemistry, Chemistry Institute, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ 21941909, Brazil; Center for Food Analysis (NAL), Technological Development Support Laboratory (LADETEC), Chemistry Institute, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ 21941598, Brazil; Nanotechnology Network, Carlos Chagas Filho Research Support Foundation of the State of Rio de Janeiro (FAPERJ), Rio de Janeiro, RJ 20020-000, Brazil; Graduate Program in Chemistry (PGQu), Chemistry Institute, Federal University of Rio de Janeiro, Rio de Janeiro, RJ 21941909, Brazil
| |
Collapse
|
4
|
Liang S. Advances in drug delivery applications of modified bacterial cellulose-based materials. Front Bioeng Biotechnol 2023; 11:1252706. [PMID: 37600320 PMCID: PMC10436498 DOI: 10.3389/fbioe.2023.1252706] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2023] [Accepted: 07/24/2023] [Indexed: 08/22/2023] Open
Abstract
Bacterial cellulose (BC) is generated by certain species of bacteria and comprises polysaccharides with unique physical, chemical, and mechanical characteristics. Due to its outstanding biocompatibility, high purity, excellent mechanical strength, high water absorption, and highly porous structure, bacterial cellulose has been recently investigated for biomedical application. However, the pure form of bacterial cellulose is hardly used as a biomedical material due to some of its inherent shortcomings. To extend its applications in drug delivery, modifications of native bacterial cellulose are widely used to improve its properties. Usually, bacterial cellulose modifications can be carried out by physical, chemical, and biological methods. In this review, a brief introduction to bacterial cellulose and its production and fabrication is first given, followed by up-to-date and in-depth discussions of modification. Finally, we focus on the potential applications of bacterial cellulose as a drug delivery system.
Collapse
Affiliation(s)
- Shuya Liang
- Department of Dermatology, Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
| |
Collapse
|
5
|
Li Z, Wang J, Wang Z, Xu Y. Towards an optimal model for gastric cancer peritoneal metastasis: current challenges and future directions. EBioMedicine 2023; 92:104601. [PMID: 37182268 DOI: 10.1016/j.ebiom.2023.104601] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2023] [Revised: 04/08/2023] [Accepted: 04/19/2023] [Indexed: 05/16/2023] Open
Abstract
Peritoneal metastasis is a challenging aspect of clinical practice for gastric cancer. Animal models are crucial in understanding molecular mechanisms, assessing drug efficacy, and conducting clinical intervention studies, including those related to gastric cancer peritoneal metastasis. Unlike other xenograft models, peritoneal metastasis models should not only present tumor growth at the transplant site, but also recapitulate tumor cell metastasis in the abdominal cavity. Developing a reliable model of gastric cancer peritoneal metastasis involves several technical aspects, such as the selection of model animals, source of xenograft tumors, technology of transplantation, and dynamic monitoring of the tumor progression. To date, challenges remain in developing a reliable model that can completely recapitulate peritoneal metastasis. Thus, this review aims to summarize the techniques and strategies used to establish animal models of gastric cancer peritoneal metastasis, providing a reference for future model establishment.
Collapse
Affiliation(s)
- Zehui Li
- Department of Surgical Oncology and General Surgery, First Hospital of China Medical University, Shenyang, 110001, PR China
| | - Jin Wang
- Department of E.N.T., Shengjing Hospital of China Medical University, Shenyang, 110003, PR China
| | - Zhenning Wang
- Department of Surgical Oncology and General Surgery, First Hospital of China Medical University, Shenyang, 110001, PR China.
| | - Yan Xu
- Department of Surgical Oncology and General Surgery, First Hospital of China Medical University, Shenyang, 110001, PR China.
| |
Collapse
|
6
|
Ramezanpour A, Ansari L, Rahimkhoei V, Sharifi S, Bigham A, Lighvan ZM, Rezaie J, Szafert S, Mahdavinia G, Akbari A, Jabbari E. Recent advances in carbohydrate-based paclitaxel delivery systems. Polym Bull (Berl) 2023. [DOI: 10.1007/s00289-023-04759-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023]
|
7
|
Ong XR, Chen AX, Li N, Yang YY, Luo HK. Nanocellulose: Recent Advances Toward Biomedical Applications. SMALL SCIENCE 2022. [DOI: 10.1002/smsc.202200076] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022] Open
Affiliation(s)
- Xuan-Ran Ong
- Agency for Science, Technology and Research Institute of Sustainability for Chemicals, Energy and Environment 1 Pesek Road, Jurong Island Singapore 627833 Singapore
| | - Adrielle Xianwen Chen
- Agency for Science, Technology and Research Institute of Bioengineering and Bioimaging 31 Biopolis Way Singapore 138669 Singapore
| | - Ning Li
- Agency for Science, Technology and Research Institute of Bioengineering and Bioimaging 31 Biopolis Way Singapore 138669 Singapore
| | - Yi Yan Yang
- Agency for Science, Technology and Research Institute of Bioengineering and Bioimaging 31 Biopolis Way Singapore 138669 Singapore
| | - He-Kuan Luo
- Agency for Science, Technology and Research Institute of Sustainability for Chemicals, Energy and Environment 1 Pesek Road, Jurong Island Singapore 627833 Singapore
| |
Collapse
|
8
|
Castaño M, Martínez E, Osorio M, Castro C. Development of Genistein Drug Delivery Systems Based on Bacterial Nanocellulose for Potential Colorectal Cancer Chemoprevention: Effect of Nanocellulose Surface Modification on Genistein Adsorption. Molecules 2022; 27:molecules27217201. [PMID: 36364026 PMCID: PMC9656560 DOI: 10.3390/molecules27217201] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2022] [Revised: 10/03/2022] [Accepted: 10/07/2022] [Indexed: 12/01/2022] Open
Abstract
Genistein is an isoflavone with antioxidant, anti-inflammatory, and anticancer properties. That said, its use in the industry is limited by its low solubility in aqueous systems. In this work, bacterial nanocellulose (BNC) and BNC modified with cetyltrimethylammonium (BNC-CTAB) were evaluated as genistein-encapsulating materials for their controlled release in cancer chemoprevention. Thin films were obtained and characterized by contact angle, AFM, TEM, UV–Vis spectroscopy FTIR, and TGA techniques to verify surface modification and genistein encapsulation. The results show a decrease in hydrophilization degree and an increase in diameter after BNC modification. Furthermore, the affinity of genistein with the encapsulating materials was determined in the context of monolayer and multilayer isotherms, thermodynamic parameters and adsorption kinetics. Spontaneous, endothermic and reversible adsorption processes were found for BNC-GEN and BNC-CTAB-GEN. After two hours, the maximum adsorption capacity corresponded to 4.59 mg GEN∙g−1 BNC and 6.10 mg GEN∙g−1 BNC-CTAB; the latter was a more stable system. Additionally, in vitro release assays performed with simulated gastrointestinal fluids indicated controlled and continuous desorption in gastric and colon fluids, with a release of around 5% and 85%, respectively, for either system. Finally, the IC50 tests made it possible to determine the amounts of films required to achieve therapeutic concentrations for SW480 and SW620 cell lines.
Collapse
Affiliation(s)
- Melissa Castaño
- School of Engineering, Universidad Pontificia Bolivariana, Circular 1#70-01, Medellín 050031, Colombia
| | - Estefanía Martínez
- School of Engineering, Universidad Pontificia Bolivariana, Circular 1#70-01, Medellín 050031, Colombia
| | - Marlon Osorio
- School of Engineering, Universidad Pontificia Bolivariana, Circular 1#70-01, Medellín 050031, Colombia
- School of Health Science, Biology Systems Research Group, Universidad Pontificia Bolivariana, Calle 78b #72a-159, Medellín 050031, Colombia
| | - Cristina Castro
- School of Engineering, Universidad Pontificia Bolivariana, Circular 1#70-01, Medellín 050031, Colombia
- Correspondence:
| |
Collapse
|
9
|
Tang KY, Heng JZX, Chai CHT, Chan CY, Low BQL, Chong SME, Loh HY, Li Z, Ye E, Loh XJ. Modified Bacterial Cellulose for Biomedical Applications. Chem Asian J 2022; 17:e202200598. [DOI: 10.1002/asia.202200598] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2022] [Revised: 07/30/2022] [Indexed: 11/09/2022]
Affiliation(s)
- Karen Yuanting Tang
- Institute of Materials Research and Engineering Strategic Research Initiative 2 Fusionopolis Way, Innovis, #08-03 138634 Singapore SINGAPORE
| | - Jerry Zhi Xiong Heng
- Institute of Materials Research and Engineering Strategic Research Initiative 2 Fusionopolis Way, Innovis, #08-03 138634 Singapore SINGAPORE
| | - Casandra Hui Teng Chai
- Institute of Materials Research and Engineering Strategic Research Initiative 2 Fusionopolis Way, Innovis, #08-03 138634 Singapore SINGAPORE
| | - Chui Yu Chan
- Institute of Materials Research and Engineering Strategic Research Initiative 2 Fusionopolis Way, Innovis, #08-03 138634 Singapore SINGAPORE
| | - Beverly Qian Ling Low
- National University of Singapore Department of Materials Science and Engineering SINGAPORE
| | - Serene Ming En Chong
- Singapore Institute of Technology Food, Chemical and Biotechnology Cluster SINGAPORE
| | - Hong Yi Loh
- Nanyang Technological University Department of Materials Science and Engineering SINGAPORE
| | - Zibiao Li
- Institute of Materials Research and Engineering Strategic Research Initiative 2 Fusionopolis Way, Innovis, #08-03 138634 Singapore SINGAPORE
| | - Enyi Ye
- Institute of Materials Research and Engineering Strategic Research Initiative 2 Fusionopolis Way, Innovis, #8-03 138634 Singapore SINGAPORE
| | - Xian Jun Loh
- Institute of Materials Research and Engineering Strategic Research Initiative 2 Fusionopolis Way, Innovis, #08-03 138634 Singapore SINGAPORE
| |
Collapse
|
10
|
Singhania RR, Patel AK, Tseng YS, Kumar V, Chen CW, Haldar D, Saini JK, Dong CD. Developments in bioprocess for bacterial cellulose production. BIORESOURCE TECHNOLOGY 2022; 344:126343. [PMID: 34780908 DOI: 10.1016/j.biortech.2021.126343] [Citation(s) in RCA: 21] [Impact Index Per Article: 10.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/22/2021] [Revised: 11/08/2021] [Accepted: 11/09/2021] [Indexed: 06/13/2023]
Abstract
Bacterial cellulose (BC) represents a novel bio-origin nonomaterial with its unique properties having diverse applications. Increased market demand and low yield are the major reason for its higher cost. Bacteria belonging to Komagataeibacter sp are the most exploited ones for BC production. Development of a cost-effective bioprocess for higher BC production is desirable. Though static fermentation modes have been majorly employed for BC production using tray fermenters, agitated mode has also been employed successfully with air-lift fermenters as well as stirred tank reactors. Bioprocess advances in recent years has led BC production to an upper level; however, challenges of aeration requirement and labor cost towards the higher end is associated with static cultivation at large scale. We have discussed the bioprocess development for BC production in recent years along with the challenges associated and the path forward.
Collapse
Affiliation(s)
- Reeta Rani Singhania
- Department of Marine Environmental Engineering, National Kaohsiung University of Science and Technology, Kaohsiung City 81157, Taiwan
| | - Anil Kumar Patel
- Department of Marine Environmental Engineering, National Kaohsiung University of Science and Technology, Kaohsiung City 81157, Taiwan
| | - Yi-Sheng Tseng
- Department of Marine Environmental Engineering, National Kaohsiung University of Science and Technology, Kaohsiung City 81157, Taiwan
| | - Vinod Kumar
- Fermentation Technology Division, Indian Institute of Integrative Medicine, Post Bag No. 3, Canal Road, Jammu 180001, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India
| | - Chiu-Wen Chen
- Department of Marine Environmental Engineering, National Kaohsiung University of Science and Technology, Kaohsiung City 81157, Taiwan
| | - Dibyajyoti Haldar
- Department of Biotechnology, Karunya Institute of Technology and Sciences, Coimbatore 641114, India
| | - Jitendra Kumar Saini
- Department of Microbiology, Central University of Haryana, Mahendragarh 123031, Haryana, India
| | - Cheng-Di Dong
- Department of Marine Environmental Engineering, National Kaohsiung University of Science and Technology, Kaohsiung City 81157, Taiwan.
| |
Collapse
|
11
|
Curvello R, Kast V, Abuwarwar MH, Fletcher AL, Garnier G, Loessner D. 3D Collagen-Nanocellulose Matrices Model the Tumour Microenvironment of Pancreatic Cancer. Front Digit Health 2021; 3:704584. [PMID: 34713176 PMCID: PMC8521838 DOI: 10.3389/fdgth.2021.704584] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2021] [Accepted: 06/29/2021] [Indexed: 01/18/2023] Open
Abstract
Three-dimensional (3D) cancer models are invaluable tools designed to study tumour biology and new treatments. Pancreatic ductal adenocarcinoma (PDAC), one of the deadliest types of cancer, has been progressively explored with bioengineered 3D approaches by deconstructing elements of its tumour microenvironment. Here, we investigated the suitability of collagen-nanocellulose hydrogels to mimic the extracellular matrix of PDAC and to promote the formation of tumour spheroids and multicellular 3D cultures with stromal cells. Blending of type I collagen fibrils and cellulose nanofibres formed a matrix of controllable stiffness, which resembled the lower profile of pancreatic tumour tissues. Collagen-nanocellulose hydrogels supported the growth of tumour spheroids and multicellular 3D cultures, with increased metabolic activity and matrix stiffness. To validate our 3D cancer model, we tested the individual and combined effects of the anti-cancer compound triptolide and the chemotherapeutics gemcitabine and paclitaxel, resulting in differential cell responses. Our blended 3D matrices with tuneable mechanical properties consistently maintain the growth of PDAC cells and its cellular microenvironment and allow the screening of anti-cancer treatments.
Collapse
Affiliation(s)
- Rodrigo Curvello
- Department of Chemical Engineering, Faculty of Engineering, Monash University, Clayton, VIC, Australia
| | - Verena Kast
- Max Bergmann Center of Biomaterials Dresden, Leibniz Institute of Polymer Research Dresden E.V., Dresden, Germany
| | - Mohammed H Abuwarwar
- Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia
| | - Anne L Fletcher
- Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia
| | - Gil Garnier
- Department of Chemical Engineering, Faculty of Engineering, Monash University, Clayton, VIC, Australia.,Department of Chemical Engineering, Bioresource Processing Research Institute of Australia (BioPRIA), Monash University, Clayton, VIC, Australia
| | - Daniela Loessner
- Department of Chemical Engineering, Faculty of Engineering, Monash University, Clayton, VIC, Australia.,Department of Materials Science and Engineering, Faculty of Engineering, Monash University, Clayton, VIC, Australia.,Department of Anatomy and Developmental Biology, Biomedicine Discovery Institute, Faculty of Medicine, Nursing and Health Science, Monash University, Clayton, VIC, Australia
| |
Collapse
|
12
|
Doxorubicin Embedded into Nanofibrillated Bacterial Cellulose (NFBC) Produces a Promising Therapeutic Outcome for Peritoneally Metastatic Gastric Cancer in Mice Models via Intraperitoneal Direct Injection. NANOMATERIALS 2021; 11:nano11071697. [PMID: 34203462 PMCID: PMC8307241 DOI: 10.3390/nano11071697] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/13/2021] [Revised: 06/23/2021] [Accepted: 06/25/2021] [Indexed: 02/06/2023]
Abstract
Natural materials such as bacterial cellulose are gaining interest for their use as drug-delivery vehicles. Herein, the utility of nanofibrillated bacterial cellulose (NFBC), which is produced by culturing a cellulose-producing bacterium (Gluconacetobacter intermedius NEDO-01) in a medium supplemented with carboxymethylcellulose (CMC) that is referred to as CM-NFBC, is described. Recently, we demonstrated that intraperitoneal administration of paclitaxel (PTX)-containing CM-NFBC efficiently suppressed tumor growth in a peritoneally disseminated cancer xenograft model. In this study, to confirm the applicability of NFBC in cancer therapy, a chemotherapeutic agent, doxorubicin (DXR), embedded into CM-NFBC, was examined for its efficiency to treat a peritoneally disseminated gastric cancer via intraperitoneal administration. DXR was efficiently embedded into CM-NFBC (DXR/CM-NFBC). In an in vitro release experiment, 79.5% of DXR was released linearly into the peritoneal wash fluid over a period of 24 h. In the peritoneally disseminated gastric cancer xenograft model, intraperitoneal administration of DXR/CM-NFBC induced superior tumor growth inhibition (TGI = 85.5%) by day 35 post-tumor inoculation, compared to free DXR (TGI = 62.4%). In addition, compared with free DXR, the severe side effects that cause body weight loss were lessened via treatment with DXR/CM-NFBC. These results support the feasibility of CM-NFBC as a drug-delivery vehicle for various anticancer agents. This approach may lead to improved therapeutic outcomes for the treatment of intraperitoneally disseminated cancers.
Collapse
|